Atlas Trials

Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant

Clinical trial NCT05405387 · RECRUITING

Trial details

NCT number
NCT05405387
Sponsor
University of Utah
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple MyelomaPlasma Cell Leukemia
Start date
2023-05-03
Primary completion
2026-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.